 PONTE VEDRA, Fla., Sept. 23, 2021 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace Nasdaq: TMCI, a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of hallux valgus commonly known as bunions through its Lapiplasty 3D Bunion CorrectionTM procedure, today announced the presentation of new data at the ongoing 2021 American Orthopaedic Foot Ankle Society AOFAS Annual Meeting in Charlotte, North Carolina. Updated interim analysis from the ALIGN3DTM clinical study demonstrated positive radiographic and patient-reported outcomes starting at 6 weeks and maintained at 24 months following the Lapiplasty procedure. 